In 25% of Breast Lumpectomy surgeries, cancerous material is left behind.
With current technology, the surgeon needs to wait about a week, to see if he’s got all the cancerous…
pre-commercialisation
No need to cut the patient open again later. The surgeon can make adjustments on the fly….
PINK is accelerating toward the commercialisation of the OTIS platform. It has already received a $7.4 million grant (non-dilutive capital) from the Cancer Prevention and Research Institute of Texas…
Nano One (NNO.V) has developed proprietary technology to build a better and cheaper battery. NNO’s scaled process can make cathode materials using the cheaper lithium carbonate in place of…